Literature DB >> 26961897

Chronic idiopathic axonal polyneuropathy: a systematic review.

Panagiotis Zis1,2, Ptolemaios Georgios Sarrigiannis3, Dasappaiah Ganesh Rao3, Channa Hewamadduma3, Marios Hadjivassiliou3,4.   

Abstract

Chronic idiopathic axonal polyneuropathy (CIAP) is a term describing neuropathies with both sensory and motor involvement in a length dependant distribution where neurophysiology reveals axonal damage, neuropathy onset is insidious and shows slow or no progression of the disease over at least 6 months with no aetiology being identified despite appropriate investigations. This entity merits further consideration given how common it is, the absence of clarity regarding aetiopathogenesis, natural history and therapies. A systematic computer-based literature search was conducted on PubMed database. We used two Medical Subject Headings terms in title. Term A was "axonal", "cryptogenic", "idiopathic" or "unknown" and Term B was "neuropathy" or "polyneuropathy". This search strategy resulted in the identification of 658 articles. After eligibility assessment, 48 papers were used for this review. CIAP is usually diagnosed in the sixth decade of life and it is more prevalent in males (ratio 3:2). It is usually slowly progressive. Some data support a potential role of autoimmunity in CIAP and further larger prospective studies are required to address such potential link and any treatment implications. CIAP is a common type of polyneuropathy but the least studied. Increasing awareness and research into this entity may result in better understanding and in the development of treatment strategies.

Entities:  

Keywords:  Axonal; CIAP; Idiopathic; Polyneuropathy

Mesh:

Year:  2016        PMID: 26961897     DOI: 10.1007/s00415-016-8082-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  62 in total

1.  Antibody panels in idiopathic polyneuropathy and motor neuron disease.

Authors:  G I Wolfe; W H El-Feky; J S Katz; W W Bryan; F H Wians; R J Barohn
Journal:  Muscle Nerve       Date:  1997-10       Impact factor: 3.217

2.  Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics.

Authors:  G I Wolfe; N S Baker; A A Amato; C E Jackson; S P Nations; D S Saperstein; C H Cha; J S Katz; W W Bryan; R J Barohn
Journal:  Arch Neurol       Date:  1999-05

3.  Statins and risk of polyneuropathy: a case-control study.

Authors:  D Gaist; U Jeppesen; M Andersen; L A García Rodríguez; J Hallas; S H Sindrup
Journal:  Neurology       Date:  2002-05-14       Impact factor: 9.910

Review 4.  Impaired glucose tolerance and metabolic syndrome in idiopathic neuropathy.

Authors:  A Gordon Smith
Journal:  J Peripher Nerv Syst       Date:  2012-05       Impact factor: 3.494

5.  Cryptogenic polyneuropathy: clinical and neurophysiological findings.

Authors:  Jonas Lindh; Martin Tondel; Anders Osterberg; Magnus Vrethem
Journal:  J Peripher Nerv Syst       Date:  2005-03       Impact factor: 3.494

6.  Health-related quality of life in patients with cryptogenic polyneuropathy compared with the general population.

Authors:  Jonas Lindh; Martin Tondel; Bodil Persson; Magnus Vrethem
Journal:  Disabil Rehabil       Date:  2010-08-07       Impact factor: 3.033

7.  Functioning of patients with chronic idiopathic axonal polyneuropathy (CIAP).

Authors:  Peter G Erdmann; Laurien L Teunissen; Frank R van Genderen; Nicolette C Notermans; Eline Lindeman; Paul J M Helders; Nico L U van Meeteren
Journal:  J Neurol       Date:  2007-03-25       Impact factor: 4.849

8.  Prevalence of peripheral neuropathy in the Parsi community of Bombay.

Authors:  N E Bharucha; A E Bharucha; E P Bharucha
Journal:  Neurology       Date:  1991-08       Impact factor: 9.910

9.  Increase of sural nerve T cells in progressive axonal polyneuropathy and monoclonal gammopathy.

Authors:  M Eurelings; L H van den Berg; J H J Wokke; H Franssen; A F J E Vrancken; N C Notermans
Journal:  Neurology       Date:  2003-09-09       Impact factor: 9.910

10.  A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy.

Authors:  R A C Hughes; T Umapathi; I A Gray; N A Gregson; M Noori; A S Pannala; A Proteggente; A V Swan
Journal:  Brain       Date:  2004-06-16       Impact factor: 13.501

View more
  25 in total

Review 1.  Immune-mediated neuropathies.

Authors:  Bernd C Kieseier; Emily K Mathey; Claudia Sommer; Hans-Peter Hartung
Journal:  Nat Rev Dis Primers       Date:  2018-10-11       Impact factor: 52.329

2.  Gluten neuropathy: prevalence of neuropathic pain and the role of gluten-free diet.

Authors:  Panagiotis Zis; Ptolemaios Georgios Sarrigiannis; Dasappaiah Ganesh Rao; Marios Hadjivassiliou
Journal:  J Neurol       Date:  2018-07-21       Impact factor: 4.849

3.  RFC1 expansions are a common cause of idiopathic sensory neuropathy.

Authors:  Riccardo Currò; Alessandro Salvalaggio; Stefano Tozza; Chiara Gemelli; Natalia Dominik; Valentina Galassi Deforie; Francesca Magrinelli; Francesca Castellani; Elisa Vegezzi; Pietro Businaro; Ilaria Callegari; Anna Pichiecchio; Giuseppe Cosentino; Enrico Alfonsi; Enrico Marchioni; Silvia Colnaghi; Simone Gana; Enza Maria Valente; Cristina Tassorelli; Stephanie Efthymiou; Stefano Facchini; Aisling Carr; Matilde Laura; Alexander M Rossor; Hadi Manji; Michael P Lunn; Elena Pegoraro; Lucio Santoro; Marina Grandis; Emilia Bellone; Nicholas J Beauchamp; Marios Hadjivassiliou; Diego Kaski; Adolfo M Bronstein; Henry Houlden; Mary M Reilly; Paola Mandich; Angelo Schenone; Fiore Manganelli; Chiara Briani; Andrea Cortese
Journal:  Brain       Date:  2021-06-22       Impact factor: 13.501

4.  Rapid neurophysiological screening for sensory ganglionopathy: A novel approach.

Authors:  Panagiotis Zis; Marios Hadjivassiliou; Ptolemaios Georgios Sarrigiannis; Alexander St John Edward Barker; Dasappaiah Ganesh Rao
Journal:  Brain Behav       Date:  2017-11-24       Impact factor: 2.708

5.  Painful Peripheral Neuropathy and Cancer.

Authors:  Panagiotis Zis; Giustino Varrassi
Journal:  Pain Ther       Date:  2017-07-01

6.  A prospective, observational study of patients with uncommon distal symmetric painful small-fiber neuropathy.

Authors:  Jung-Lung Hsu; Ming-Feng Liao; Hui-Ching Hsu; Yi-Ching Weng; Ai-Lun Lo; Kuo-Hsuan Chang; Hong-Shiu Chang; Hung-Chou Kuo; Chin-Chang Huang; Long-Sun Ro
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

7.  Cerebellar ataxia with sensory ganglionopathy; does autoimmunity have a role to play?

Authors:  Panagiotis Zis; Ptolemaios Georgios Sarrigiannis; Dasappaiah Ganesh Rao; Nigel Hoggard; David Surendran Sanders; Marios Hadjivassiliou
Journal:  Cerebellum Ataxias       Date:  2017-12-22

8.  The genetic landscape of axonal neuropathies in the middle-aged and elderly: Focus on MME.

Authors:  Jan Senderek; Petra Lassuthova; Dagmara Kabzińska; Lisa Abreu; Jonathan Baets; Christian Beetz; Geir J Braathen; David Brenner; Joline Dalton; Lois Dankwa; Tine Deconinck; Peter De Jonghe; Bianca Dräger; Katja Eggermann; Melina Ellis; Carina Fischer; Tanya Stojkovic; David N Herrmann; Rita Horvath; Helle Høyer; Stephan Iglseder; Marina Kennerson; Katharina Kinslechner; Jennefer N Kohler; Ingo Kurth; Nigel G Laing; Phillipa J Lamont; Löscher Wolfgang N; Albert Ludolph; Wilson Marques; Garth Nicholson; Royston Ong; Susanne Petri; Gianina Ravenscroft; Adriana Rebelo; Giulia Ricci; Sabine Rudnik-Schöneborn; Anja Schirmacher; Beate Schlotter-Weigel; Ludger Schoels; Rebecca Schüle; Matthis Synofzik; Bruno Francou; Tim M Strom; Johannes Wagner; David Walk; Julia Wanschitz; Daniela Weinmann; Jochen Weishaupt; Manuela Wiessner; Reinhard Windhager; Peter Young; Stephan Züchner; Stefan Toegel; Pavel Seeman; Andrzej Kochański; Michaela Auer-Grumbach
Journal:  Neurology       Date:  2020-11-03       Impact factor: 9.910

Review 9.  Pharmacological Management of Painful Peripheral Neuropathies: A Systematic Review.

Authors:  Andreas Liampas; Martina Rekatsina; Athina Vadalouca; Antonella Paladini; Giustino Varrassi; Panagiotis Zis
Journal:  Pain Ther       Date:  2020-11-03

10.  A compound score to screen patients with hereditary transthyretin amyloidosis.

Authors:  Stefano Tozza; Daniele Severi; Emanuele Spina; Andrea Di Paolantonio; Aniello Iovino; Valeria Guglielmino; Francesco Aruta; Maria Nolano; Mario Sabatelli; Lucio Santoro; Marco Luigetti; Fiore Manganelli
Journal:  J Neurol       Date:  2022-03-13       Impact factor: 6.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.